1 Study Coverage
1.1 Polyvalent Streptococcus Pneumococcal Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 9-Valent
1.2.3 13-Valent
1.2.4 23-Valent
1.2.5 Others
1.3 Market by Application
1.3.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Community Clinics
1.3.4 Public Health Agencies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Region
2.4.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Polyvalent Streptococcus Pneumococcal Vaccines by Region (2023-2028)
2.5 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Region
2.5.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Region (2017-2022)
2.5.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Manufacturers
3.1.1 Global Top Polyvalent Streptococcus Pneumococcal Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Polyvalent Streptococcus Pneumococcal Vaccines in 2021
3.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Manufacturers
3.2.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Polyvalent Streptococcus Pneumococcal Vaccines Revenue in 2021
3.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type
4.1.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Type
4.2.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Price by Type
4.3.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Price by Type (2017-2022)
4.3.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application
5.1.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Application
5.2.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Price by Application
5.3.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Price by Application (2017-2022)
5.3.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Type
6.1.1 North America Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2017-2028)
6.1.2 North America Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Type (2017-2028)
6.2 North America Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Application
6.2.1 North America Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2017-2028)
6.2.2 North America Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Application (2017-2028)
6.3 North America Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Country
6.3.1 North America Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2017-2028)
6.3.2 North America Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Type
7.1.1 Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2017-2028)
7.1.2 Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Type (2017-2028)
7.2 Europe Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Application
7.2.1 Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2017-2028)
7.2.2 Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Application (2017-2028)
7.3 Europe Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Country
7.3.1 Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2017-2028)
7.3.2 Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Type
8.1.1 Asia Pacific Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Application
8.2.1 Asia Pacific Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Region
8.3.1 Asia Pacific Polyvalent Streptococcus Pneumococcal Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Type
9.1.1 Latin America Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Type (2017-2028)
9.2 Latin America Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Application
9.2.1 Latin America Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Application (2017-2028)
9.3 Latin America Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Country
9.3.1 Latin America Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Type
10.1.1 Middle East and Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Application
10.2.1 Middle East and Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Country
10.3.1 Middle East and Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GlaxoSmithKline Recent Developments
11.2 LG Chem
11.2.1 LG Chem Corporation Information
11.2.2 LG Chem Overview
11.2.3 LG Chem Polyvalent Streptococcus Pneumococcal Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 LG Chem Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 LG Chem Recent Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Overview
11.3.3 Merck Polyvalent Streptococcus Pneumococcal Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Merck Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck Recent Developments
11.4 Panacea Biotec
11.4.1 Panacea Biotec Corporation Information
11.4.2 Panacea Biotec Overview
11.4.3 Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Panacea Biotec Recent Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Corporation Information
11.5.2 AstraZeneca Overview
11.5.3 AstraZeneca Polyvalent Streptococcus Pneumococcal Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 AstraZeneca Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 AstraZeneca Recent Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pfizer Recent Developments
11.7 Shire
11.7.1 Shire Corporation Information
11.7.2 Shire Overview
11.7.3 Shire Polyvalent Streptococcus Pneumococcal Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Shire Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Shire Recent Developments
11.8 Pnuvax Incorporated
11.8.1 Pnuvax Incorporated Corporation Information
11.8.2 Pnuvax Incorporated Overview
11.8.3 Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Pnuvax Incorporated Recent Developments
11.9 Serum Institute
11.9.1 Serum Institute Corporation Information
11.9.2 Serum Institute Overview
11.9.3 Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Serum Institute Recent Developments
11.10 Shinogi
11.10.1 Shinogi Corporation Information
11.10.2 Shinogi Overview
11.10.3 Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Shinogi Recent Developments
11.11 Shenzhen Kangtai Biological Products
11.11.1 Shenzhen Kangtai Biological Products Corporation Information
11.11.2 Shenzhen Kangtai Biological Products Overview
11.11.3 Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Shenzhen Kangtai Biological Products Recent Developments
11.12 SK Bioscience
11.12.1 SK Bioscience Corporation Information
11.12.2 SK Bioscience Overview
11.12.3 SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 SK Bioscience Recent Developments
11.13 Walvax Biotechnology
11.13.1 Walvax Biotechnology Corporation Information
11.13.2 Walvax Biotechnology Overview
11.13.3 Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Walvax Biotechnology Recent Developments
11.14 Eli Lilly
11.14.1 Eli Lilly Corporation Information
11.14.2 Eli Lilly Overview
11.14.3 Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Eli Lilly Recent Developments
11.15 Abera
11.15.1 Abera Corporation Information
11.15.2 Abera Overview
11.15.3 Abera Polyvalent Streptococcus Pneumococcal Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Abera Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Abera Recent Developments
11.16 Sanofi
11.16.1 Sanofi Corporation Information
11.16.2 Sanofi Overview
11.16.3 Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Sanofi Recent Developments
11.17 Genentech
11.17.1 Genentech Corporation Information
11.17.2 Genentech Overview
11.17.3 Genentech Polyvalent Streptococcus Pneumococcal Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Genentech Polyvalent Streptococcus Pneumococcal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Genentech Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Polyvalent Streptococcus Pneumococcal Vaccines Industry Chain Analysis
12.2 Polyvalent Streptococcus Pneumococcal Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Polyvalent Streptococcus Pneumococcal Vaccines Production Mode & Process
12.4 Polyvalent Streptococcus Pneumococcal Vaccines Sales and Marketing
12.4.1 Polyvalent Streptococcus Pneumococcal Vaccines Sales Channels
12.4.2 Polyvalent Streptococcus Pneumococcal Vaccines Distributors
12.5 Polyvalent Streptococcus Pneumococcal Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Polyvalent Streptococcus Pneumococcal Vaccines Industry Trends
13.2 Polyvalent Streptococcus Pneumococcal Vaccines Market Drivers
13.3 Polyvalent Streptococcus Pneumococcal Vaccines Market Challenges
13.4 Polyvalent Streptococcus Pneumococcal Vaccines Market Restraints
14 Key Findings in The Global Polyvalent Streptococcus Pneumococcal Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer